The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Neroyev V.V.

Moscow Helmholtz Research Institute of Eye Diseases, Moscow, Russia

Kiseleva T.N.

Department of Ultrasound of Helmholtz Moscow Research Institute of Eye Diseases, Moscow, Russia

Okhotsimskaia T.D.

FGBU Moskovskiĭ nauchno-issledovatel'skiĭ institut glaznykh bolezneĭ im. Gel'mgol'tsa Minzdrava RF, Moskva

Eliseeva E.K.

Helmholtz National Medical Research Center of Eye Diseases, 14/19 Sadovaya-Chernogryazskaya St., Moscow, Russian Federation, 105062

Riabina M.V.

FGBU Moskovskiĭ nauchno-issledovatel'skiĭ institut glaznykh bolezneĭ im. Gel'mgol'tsa Minzdrava RF, Moskva

Vasil'chenko V.V.

NII neĭrokhirurgii im. N.N. Burdenko, Moskva

Bilateral occlusion of retinal vessels in Waldenstrom’s disease (a case study)

Authors:

Neroyev V.V., Kiseleva T.N., Okhotsimskaia T.D., Eliseeva E.K., Riabina M.V., Vasil'chenko V.V.

More about the authors

Journal: Russian Annals of Ophthalmology. 2020;136(1): 90‑96

Read: 2642 times


To cite this article:

Neroyev VV, Kiseleva TN, Okhotsimskaia TD, Eliseeva EK, Riabina MV, Vasil'chenko VV. Bilateral occlusion of retinal vessels in Waldenstrom’s disease (a case study). Russian Annals of Ophthalmology. 2020;136(1):90‑96. (In Russ.)
https://doi.org/10.17116/oftalma202013601190

Recommended articles:

References:

  1. Gertz MA, Fonseca R, Rajkumar SV. Waldenström’s macroglobulinemia. The Oncologist. 2000;5(1):63-67. https://doi.org/10.1634/theoncologist.5-1-63
  2. Kapoor P, Ansell SM, Fonseca R, Chanan-Khan A, Kyle RA, Kumar SK, Ailawadhi S. Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines. JAMA Oncology. 2017;3(9):1257-1265. https://doi.org/10.1001/jamaoncol.2016.5763
  3. Leblond V, Dimopoulos MA, Treon SP. Treatment Recommendations in Waldenström Macroglobulinemia. Waldenström’s Macroglobulinemia. 2017; 367-370. https://doi.org/10.1007/978-3-319-22584-5_26
  4. Gordeev IG, Soboleva VN, Volov NA, Mashykova Yu.M., Vishchipanova TE. Waldenstrom macroglobulinemia in the clinical practice of a physician – the difficulty of diagnosis. Terapevt. 2017;5:57-62. (In Russ.).
  5. Treon SP, Merlini G, Dimopoulos M. Waldenstrom’s Macroglobulinemia. Neoplastic Diseases of the Blood. 2018:617-638. https://doi.org/10.1007/978-3-319-25586-6_11
  6. Treon SP, Hunter Z, Aggarwal A, Ewen EP, Masota S, Lee C, Tournilhac O. Characterization of familial Waldenstrom’s macroglobulinemia. Annals of Oncology. 2005;17:488-494. https://doi.org/10.1093/annonc/mdj111
  7. Hunter ZR, Yang G, Xu L, Liu X Castillo JJ, Treon SP. Genomics, signaling, and treatment of Waldenström macroglobulinemia. Journal of Clinical Oncology. 2017;35(9):994-1001. https://doi.org/10.1200/jco.2016.71.0814
  8. Giordano T. Role of hepatitis C in Waldenstrom’s macroglobulinemia. Proceedings of the 5th International Workshop on Waldenstrom’s acroglobulinemia, Stockholm, Sweden 2008 (Abstract 117).
  9. Vasil’ev VI, Probatova NA, Tupicyn NN, Varlamova EY, Logvinenko OA, Kovrigina AM, Sholohova EN, Simonova MV, Safonova TN, Gorodetsky VR, Kokosadze NV, Pavlovskaya AM, Kondratjeva TN, Gayduk IV, Kadagidze ZG. Lymphoproliferative diseases in primary sjogren’s syndrome. Onkogematologiya. 2007;3:16-26. (In Russ.).
  10. Logvinenko OA, Vasil’ev VI. Association between Sjogren’s disease and lymphomas. Nauchno-prakticheskaya revmatologiya. 2006;(3):67-76. (In Russ.).
  11. Paiva B, Corchete LA, Vidriales MB, García-Sanz R, Perez JJ, Aires-Mejia I, Sarasquete ME. The cellular origin and malignant transformation of Waldenström macroglobulinemia Blood. 2015;125(15):2370-2380. https://doi.org/10.1182/blood-2014-09-602565
  12. Poulain S. Roumier C, Venet-Caillault A, Figeac M, Herbaux C, Marot G, Nibourel O. Genomic landscape of CXCR4 mutations in Waldenström macroglobulinemia. Clinical Cancer Research. 2016;22(6):1480-1488 https://doi.org/10.1158/1078-0432.ccr-15-0646
  13. Kozlovskaya LV, Rameev VV, Mrykhin NN, Kogarko IN, Kogarko BS Kidney injury associated with monoclonal gammopathies: Perspectives on diagnosis and treatment. Terapevticheskij arhiv (arhiv do 2018 g.). 2015;87(6):108-111. (In Russ.). https://doi.org/10.17116/terarkh2015876108-111
  14. Kim W, Kweon E. Hyperviscosity-related retinopathy in Waldenström’s macroglobulinemia. New England Journal of Medicine. 2016; 374 (1):73-73. https://doi.org/10.1056/nejmicm1501103
  15. Menke MN, Kweon E. Hyperviscosity-related retinopathy in Waldenström macroglobulinemia. Archives of ophthalmology. 2006;124(11):1601-1606. https://doi.org/10.1001/archopht.124.11.1601
  16. Alexander P, Flanagan D, Rege K, Foss A, Hingorani M. Bilateral simultaneous central retinal vein occlusion secondary to hyperviscosity in Waldenstrom’s macroglobulinaemia. Eye. 2008;22(8):1089-1092. https://doi.org/10.1038/eye.2008.193
  17. Merlini G, Baldini L, Broglia C, Comelli M, Goldaniga M, Palladini G, Gobbi PG. Prognostic factors in symptomatic Waldenstrom’s macroglobulinemia. Seminars in oncology. 2003;30(2):211-215. https://doi.org/10.1053/sonc.2003.50064
  18. Lee SE, Shin YU, Lim HW, Seong MC, Cho HY, Kang MH. Bilateral Simultaneous Central Retinal Vein Occlusion in a Patient with Waldenstrom’s Macroglobulinemia. Journal of the Korean Ophthalmological Society. 2016;57(6):1012-1017. https://doi.org/10.3341/jkos.2016.57.6.1012
  19. Li W, Chalam KV, Grover S. Bilateral Choroidal Detachment in Waldenström Macroglobulinemia. JAMA Ophthalmology. 2015;133(6):715-716. https://doi.org/10.1001/jamaophthalmol.2015.64
  20. Choi RY, Jacoby R, Shakoor A. Multimodality ocular imaging in a case report of hyperviscosity syndrome associated with lymphoplasmacytic leukemia: the images tell the story. Retinal cases & brief reports. 2019;13(3):238-240. https://doi.org/10.1097/icb.0000000000000565
  21. Lapsia S, Meyer R, Abazari A, Usmani K, Gathungu G. Bilateral Central Retinal Vein Occlusion in a patient with Ulcerative Colitis and Antiphospholipid Antibody Syndrome. Journal of pediatric gastroenterology and nutrition. 2016;62(3):25-26. https://doi.org/10.1097/mpg.0000000000000404
  22. Stone MJ, Bogen SA. Evidence-based focused review of management of hyperviscosity syndrome. Blood. 2012;119(10):2205-2208. https://doi.org/10.1182/blood-2011-04-347690

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.